Drug intelligence / Profile preview

norcyclobenzaprine

Development stage
Unknown
Lead developer
Tonix Pharmaceuticals
Modality
Small Molecules
01

Overview

Norcyclobenzaprine (also known as desmethylcyclobenzaprine) is a major active metabolite of cyclobenzaprine, a muscle relaxant commonly marketed under the brand name Flexeril. Norcyclobenzaprine shares structural similarity with its parent compound and is formed in the body through demethylation. Both cyclobenzaprine and norcyclobenzaprine are potent antagonists of the serotonin 2a receptor. While cyclobenzaprine is used clinically to treat muscle spasms associated with acute musculoskeletal conditions, norcyclobenzaprine itself is not marketed as an independent pharmaceutical product but may contribute to the pharmacological effects and side effect profile of cyclobenzaprine therapy[9].

Other names
norcyclobenzaprinedesmethylcyclobenzaprine
02

Targets

ADRA2B (α2B)HRH1 (Histamine H1 Receptor)HTR2A (Serotonin receptor 5-HT2A)M1 (Muscarinic acetylcholine receptor M1)HTR2C (5-hydroxytryptamine 2C receptor)ADRA2C (α2C)ADRA1A (α1A)

Beyond the preview

Go deeper on norcyclobenzaprine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on norcyclobenzaprine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call